Brief: Medivir Agrees With Lonza To Manufacture Fostrox GMP Campaign

Medivir AB

13/12/2023 10:41

Dec 13 (Reuters) - Medivir AB  MEDIVIR.ST :
    * MEDIVIR HAVE AGREED WITH LONZA TO MANUFACTURE A FOSTROX
GMP
CAMPAIGN, TO BE TESTED IN 2L HCC WITH INTENT TO COMMERCIALIZE
VIA ACCELERATED APPROVAL
    * SIGNED AN AGREEMENT WITH LONZA FOR MANUFACTURE OF A NEW
GMP
CAMPAIGN OF FOSTROX DRUG SUBSTANCE FOR PLANNED PHASE 2B TO
ENABLE STUDY DRUG AVAILABILITY END OF 2024 AND ENSURE MAXIMUM
MOMENTUM IN FOSTROX DEVELOPMENT PROGRAM

Source text for Eikon:  ID:nWkr3snkRr 
Further company coverage:  MEDIVIR.ST 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))